Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck returns $50M anti-clotting drug betrixaban to Portola
Merck returns $50M anti-clotting drug betrixaban to Portola
Merck returns $50M anti-clotting drug betrixaban to Portola
Submitted by
admin
on March 24, 2011 - 3:14pm
Source:
bizjournals.com
News Tags:
Merck
betrixaban
Portola Pharmaceuticals
anti-clotting
Headline:
Merck returns $50M anti-clotting drug betrixaban to Portola
Do Not Allow Advertisers to Use My Personal information
